-
公开(公告)号:DE69432219D1
公开(公告)日:2003-04-10
申请号:DE69432219
申请日:1994-05-20
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , FRITZ THOMAS A , MATSUNAGA TERRY , RAMASWAMI VARADARAJAN , YELLOWHAIR DAVID , WU GUANLI
IPC: A61B8/00 , A61K8/14 , A61K9/127 , A61K41/00 , A61K47/48 , A61K49/00 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q19/00 , B01J13/02
Abstract: Methods of and apparatus for preparing temperature activated gaseous precursor-filled liposomes are described. Gaseous precursor-filled liposomes prepared by these methods are particularly useful, for example, in ultrasonic imaging applications and in therapeutic drug delivery systems.
-
公开(公告)号:AT227960T
公开(公告)日:2002-12-15
申请号:AT94919184
申请日:1994-05-19
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , FRITZ THOMAS A , MATSUNAGA TERRY , RAMASWAMI VARADARAJAN , YELLOWHAIR DAVID , WU GUANLI
IPC: A61B8/00 , A61K8/14 , A61K9/127 , A61K41/00 , A61K47/48 , A61K48/00 , A61K49/00 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q19/00 , B01J13/02
Abstract: Methods of and apparatus for preparing gas-filled liposomes are described. Gas-filled liposomes prepared by these methods are particularly useful, for example, in ultrasonic imaging applications and in therapeutic drug delivery systems.
-
公开(公告)号:AU703846B2
公开(公告)日:1999-04-01
申请号:AU7594796
申请日:1996-06-06
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , MCCREERY THOMAS , YELLOWHAIR DAVID , BARRETTE TERRENCE R
IPC: A61K49/00 , A61B5/055 , A61B8/00 , A61J3/00 , A61K8/14 , A61K8/70 , A61K9/127 , A61K41/00 , A61K47/48 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q19/00 , B01F3/04 , B01F11/00 , B01F15/00 , A61B5/00
Abstract: A method and apparatus for making vesicles suitable for use as contrast agents in which a container containing an aqueous suspension phase and a separate gas phase is shaken using reciprocating motion. The reciprocating motion is produced by a shaker arm that moves the container in two, substantially perpendicular directions, with the motion in the first direction being along an arcuate path. The overall path of the motion occurs in a figure-8 eight pattern. The frequency of shaking is at least approximately 2800 RPM, the length of the shaker arm is at least approximately 6 cm, and the angle through which the shaker arm rotates in the first direction is at least approximately 3 DEG . The total length of travel around the figure-8 pattern is at least 0.7 cm.
-
公开(公告)号:AU2451097A
公开(公告)日:1997-11-19
申请号:AU2451097
申请日:1997-04-02
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , FRITZ THOMAS , MATSUNAGA TERRY , RAMASWAMI VARADARAJAN , YELLOWHAIR DAVID , WU GUANLI
IPC: A61B8/08 , A61K8/14 , A61K9/127 , A61K41/00 , A61K47/30 , A61K47/48 , A61K49/00 , A61K49/04 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q19/00 , B01J13/02 , G01R33/28 , A61B8/13
Abstract: Lyophilized lipid compositions, as well as methods for their preparation, are embodied by the present invention. Gas-filled microspheres prepared using the lyophilized lipid composition are particularly useful, for example, in ultrasonic imaging applications and in therapeutic drug delivery systems.
-
公开(公告)号:BR9509011A
公开(公告)日:1997-09-30
申请号:BR9509011
申请日:1995-07-26
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , MATSUNAGA TERRY , YELLOWHAIR DAVID
IPC: G01R33/28 , A61B5/055 , A61J1/00 , A61K8/04 , A61K8/14 , A61K8/70 , A61K9/127 , A61K9/133 , A61K41/00 , A61K47/48 , A61K49/00 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q19/00 , B65D81/20
Abstract: A container comprising an aqueous lipid suspension and a gaseous phase substantially separate from the aqueous stabilizing phase, useful in diagnostic imaging such as ultrasound and magnetic resonance imaging and in therapeutic applications, is disclosed.
-
公开(公告)号:CA2177713A1
公开(公告)日:1995-06-08
申请号:CA2177713
申请日:1994-11-30
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: UNGER EVAN C , MATSUNAGA TERRY , YELLOWHAIR DAVID
IPC: A61B8/00 , A61K8/00 , A61K8/11 , A61K8/14 , A61K8/21 , A61K8/25 , A61K8/31 , A61K8/33 , A61K8/34 , A61K8/36 , A61K8/368 , A61K8/37 , A61K8/39 , A61K8/40 , A61K8/41 , A61K8/42 , A61K8/44 , A61K8/46 , A61K8/49 , A61K8/60 , A61K8/64 , A61K8/65 , A61K8/66 , A61K8/70 , A61K8/73 , A61K8/86 , A61K8/92 , A61K8/97 , A61K9/127 , A61K9/50 , A61K41/00 , A61K47/48 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q1/00 , A61Q1/10 , A61Q19/00 , A61K9/16 , A61K7/48
Abstract: Gas and gaseous precursor filled microspheres (1), and foams thereof, provide novel topical and subcutaneous delivery vehicles for various active ingredients, including drugs and cosmetics (2).
-
公开(公告)号:CA2164846A1
公开(公告)日:1994-12-22
申请号:CA2164846
申请日:1994-05-19
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: RAMASWAMI VARADARAJAN , UNGER EVAN C , WU GUANLI , YELLOWHAIR DAVID , MATSUNAGA TERRY , FRITZ THOMAS A
IPC: A61K8/14 , A61K9/127 , A61K9/14 , A61K41/00 , A61K47/48 , A61K49/04 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q19/00 , B28B1/54 , A61K9/16 , A61K31/70 , A61K38/17 , A61K38/19 , A61K39/00 , A61K39/395 , A61K48/00 , A61N2/00 , A61N5/00 , A61N7/00 , B01J13/02
Abstract: Therapeutic delivery systems comprising gaseous precursor-filled microspheres comprising a therapeutic are described. Methods for employing such microspheres in therapeutic delivery applications are also provided. Therapeutic delivery systems comprising gaseous precursor-filled liposomes having encapsulated therein a contrast agent or drug are preferred. Methods of and apparatus for preparing such liposomes and methods for employing such liposomes in therapeutic delivery applications are also disclosed.
-
公开(公告)号:CA2164844A1
公开(公告)日:1994-12-22
申请号:CA2164844
申请日:1994-05-19
Applicant: IMARX PHARMACEUTICAL CORP
Inventor: YELLOWHAIR DAVID , WU GUANLI , UNGER EVAN C , FRITZ THOMAS A , MATSUNAGA TERRY , RAMASWAMI VARADARAJAN
IPC: A61B8/00 , A61K8/14 , A61K9/127 , A61K41/00 , A61K47/48 , A61K48/00 , A61K49/00 , A61K49/18 , A61K49/22 , A61M5/31 , A61Q19/00 , B01J13/02 , A61K47/24
Abstract: Methods of and apparatus for preparing gas-filled liposomes are do- scribed. Gas-filled liposomes prepared by these methods are particularly use- ful, for example, in ultrasonic imaging applications and is therapeutic drug delivery systems.
-
-
-
-
-
-
-